Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_assertion type Assertion NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_head.
- NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_assertion description "[Together, our study defines NKG2D-Ls as targets for a CAR-mediated T cell based immunotherapy of ESFT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_provenance.
- NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_assertion evidence source_evidence_literature NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_provenance.
- NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_assertion SIO_000772 22355347 NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_provenance.
- NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_assertion wasDerivedFrom befree-20140225 NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_provenance.
- NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_assertion wasGeneratedBy ECO_0000203 NP631005.RASeKk3C8chv-HrtWrPM4hLixQqKoRzXou_v0r2fKs1ag130_provenance.